Sequenom Issued Additional Nasdaq Delisting Warning

NEW YORK, May 29 (GenomeWeb News) - Sequenom said last week that it has received a letter from the Nasdaq exchange notifying the company that it is currently out of compliance with the stockholder equity listing requirement.

According to Sequenom, the letter indicates that the company's stockholders' equity of $8,329,000 as of March 31 is less than the $10,000,000 requirement.

Last month, Sequenom reported that it had failed to meet the Nasdaq's minimum closing bid price requirement, and that it had until June 15 to regain compliance before its shares would be delisted from the exchange.

Sequenom said that the stockholders' equity issue could serve as an additional basis for delisting.